The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression
Author(s):
Atsumi, T.; Yamamoto, K.; Takeuchi, T.; Yamanaka, H.; Ishiguro, N.; Tanaka, Y.; Eguchi, K.; Watanabe, A.; Origasa, H.; Yasuda, S.; Yamanishi, Y.; Kita, Y.; Matsubara, T.; Iwamoto, M.; Shoji, T.; Okada, T.; Heijde, D. van der; Miyasaka, N.; Koike, T.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-01-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2016), Vol. 75, no. 1, p. 75-83
